E
EMA Events
Guest
The Nitrosamine Implementation Oversight Group (NIOG) was set up by the European medicines regulatory network to oversee the harmonised implementation of the Article 5(3) CHMP opinion on nitrosamines in human medicinal products.
The NIOG will be the main interface between regulators and industry to agree on topics requiring further scientific discussion.
This is the second meeting of the NIOG with industry stakeholders. The aim is to provide an update on progress of NIOG workplan and discuss priorities for 2022.
Sumber : https://www.ema.europa.eu
The NIOG will be the main interface between regulators and industry to agree on topics requiring further scientific discussion.
This is the second meeting of the NIOG with industry stakeholders. The aim is to provide an update on progress of NIOG workplan and discuss priorities for 2022.
Sumber : https://www.ema.europa.eu